Table 2:

Effects of age, APOE ε4, and sex on rates of change in HC

HC Measureb0bCogbEdubAge (SE; P)bAPOE (SE; P)bSex (SE; P)
Hippocampus−0.64a−0.06a−0.04a−0.04a (.01; .002)−0.42a (.13; .002)−0.25a (.13; .044)
Amygdala−0.41a−0.03−0.05−0.04a (.02; .028)−0.63a (.16; 1 × 10−4)−0.53a (.15; 5 × 10−4)
Entorhinal−0.39a−0.04−0.05−0.04a (.02; .025)−0.52a (.17; .003)−0.49a (.16; .002)
Inferior parietal−0.50a0.00−0.01−0.01 (.01; .5)−0.14 (.10; .2)0.03 (.10; .8)
Middle temporal−0.61a−0.02−0.020.00 (.01; .7)−0.19 (.12; .1)−0.02 (.11; .9)
Med-orbito-frontal−0.48a−0.03a−0.01−0.01 (.01; .5)−0.18a (.09; .050)−0.03 (.09; .8)
Whole brain−0.41a0.00−0.010.00 (.01; .8)−0.08 (.06; .2)−0.03 (.06; .7)
CDR-SB0.10a−0.010.00 (.00; .4)0.01 (.05; .9)−0.02 (.04; .6)
ADAS-Cog−0.29a−0.040.05a (.02; .008)0.27 (.20; .2)−0.21 (.18; .2)
MMSE0.02−0.02−0.02a (.01; .009)−0.14 (.08; .1)−0.06 (.08; .4)
  • Note:—b-Values are coefficients in Equation 1; for structural measures, units are annual thickness or volume change as a percentage of baseline size (%/year), and for cognitive measures they are annual score change, per ADAS-Cog unit in the case of bCog, and per year in the case of bEdu and bAge. ROIs: N = 188; mean age = 76.30 years; mean ADAS-Cog = 6.17; mean years education = 16.02. Clinical: N = 211; mean age = 76.35 years; mean years education = 16.03. SE indicates standard error; Med-orbito-frontal, medial orbito-frontal cortex.

  • a Values significant at P ≤ .05.

  • Values in the b0 column show the expected rate of change for an APOE ε4−negative male subject of mean age, mean education, and with a mean level of cognitive function. The remaining columns show the additional rate of change caused by the other factors of interest, and the amount of change experienced by a given individual can be calculated on the basis of the sum of the relevant coefficients. For example, for hippocampal atrophy, each point above the mean baseline ADAS-Cog score contributes an additional 0.06% to the annual atrophy rate; each year of education below the mean contributes an additional 0.04% to annual atrophy rate, as does each year of age above the mean at baseline; presence of an APOE ε4 allele contributes an additional 0.42% to rate of decline, and female sex contributes an additional 0.25%. Thus, an APOE ε4+ female subject, of mean age, education, and cognitive function at baseline, would show a hippocampal atrophy rate of 1.31% (0.64 + 0.42 + 0.25).